Ramm Pharma (RAMM) Stock Statistics & Valuation Metrics

Ramm Pharma has a market cap or net worth of C$1.79M. The enterprise value is C$1.07M.

Ramm Pharma has 119,389,320 shares outstanding. The number of shares has decreased by -2.65% in one year.

Ramm Pharma’s return on equity (ROE) is -1.56 and return on invested capital (ROIC) is -78.18%.

The current PE Ratio of Ramm Pharma is ―. Ramm Pharma’s PEG ratio is 0.00430.

In the last 12 months, Ramm Pharma had revenue of 3.36M and earned -8.91M in profits. Earnings per share was -0.07.

In the last 12 months, operating cash flow was -1.06M and capital expenditures 5.00, giving a free cash flow of -1.06M billion.

Ramm Pharma pays an annual dividend of ―, resulting in a dividend yield of ―

Ramm Pharma upcoming earnings date is Mar 26, 2026, Before Open (Confirmed).

Ramm Pharma as a current ratio of 0.74, with Debt / Equity ratio of 1.41%

In the past 12 months, Ramm Pharma has paid 15.25K in taxes.

Ramm Pharma EV to EBITDA ratio is -0.28, with an EV/FCF ratio of -1.01.

Ramm Pharma has C$803.88K in cash and marketable securities with C$80.39K in debt, giving a net cash position of C$723.49K billion.

Gross margin is 11.13%, with operating margin of -134.42%, and net profit margin of -265.13%.

The average price target for Ramm Pharma is ―, which is 11.43% higher than the current price. The consensus rating is ―